Biotech · Private company
Hua Medicine Limited
Track this companyFree. Adds Hua Medicine Limited to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- DorzagliatinPhase 1 · PatientsClinicalTrials.gov · fetched Nov 12, 2026
- EmpagliflozinPhase 1 · PatientsClinicalTrials.gov · fetched Nov 12, 2026
- HM-002-1005Phase 1 · Diabetes Mellitus, Type IIClinicalTrials.gov · fetched Nov 12, 2026
- HMS1005Phase 1 · Type 2 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- SitagliptinPhase 1 · PatientsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Phase 1, Multiple Ascending Dose Study to Evaluate HMS1005 in Participants With Type 2 DiabetesPHASE1 · RECRUITING · started Dec 4, 2025ClinicalTrials.gov NCT07568678 · fetched Nov 12, 2026
- Evaluate HM-002-1005 in Subjects With Type 2 Diabetes MellitusPHASE1 · COMPLETED · started Apr 25, 2024ClinicalTrials.gov NCT06498284 · fetched Nov 12, 2026
- Drug Interaction Study Between Dorzagliatin and EmpagliflozinPHASE1 · COMPLETED · started Apr 18, 2019ClinicalTrials.gov NCT03790787 · fetched Nov 12, 2026
- Drug Interaction Study Between Dorzagliatin and SitagliptinPHASE1 · COMPLETED · started Jan 31, 2019ClinicalTrials.gov NCT03790839 · fetched Nov 12, 2026